TSM5 High quality purity 99% 5mg*10vials Best Quality Peptide White Powder TSM5 Slimming Fat Burn

                                                                      whatsapp :+85266976540

                                                                                        +85252797286

This compound is an analogue of a natural endogenous peptide secreted by the hypothalamus; it stimulates the synthesis and release of growth hormone by binding to pituitary receptors. It is produced by modifying the N-terminus of the sequence with a *trans*-3-hexenoyl group. Compared to the endogenous peptide, this structural modification significantly enhances metabolic stability, extends the half-life, and reduces the rate of enzymatic degradation *in vivo*. It is typically supplied as a white, lyophilized powder in acetate form for laboratory research, with a research-grade HPLC purity of ≥99%.

Its core biological function lies in the selective targeting of receptors. Upon binding to GHRH receptors in the anterior pituitary, it activates the intracellular cyclic AMP (cAMP) signaling pathway, thereby stimulating pituitary cell activity. Elevated circulating levels of the drug subsequently stimulate the liver and peripheral tissues to synthesize and secrete insulin-like growth factor 1 (IGF-1). The GH/IGF-1 axis is involved in various physiological processes, including the regulation of body composition, lipid metabolism, connective tissue turnover, and energy balance. Unlike non-selective growth hormone secretagogues, this compound acts specifically through the GHRH receptor pathway; rather than directly mimicking growth hormone itself, it enhances the body's own growth hormone release mechanism—a key feature in peptide drug research.

One of the most extensively studied areas regarding this compound is visceral fat. Visceral adipose tissue—fat accumulating around internal abdominal organs—is closely associated with metabolic disorders such as dyslipidemia and inflammatory responses. The drug has garnered significant interest in research models targeting lipodystrophy, a condition characterized by the excessive accumulation of visceral fat. In these studies, drug-induced elevation of specific levels promotes lipolysis within visceral adipocytes, thereby accelerating fat breakdown and reducing lipid storage. Research data indicate that it significantly reduces visceral adipose tissue volume in subjects without causing a significant reduction in subcutaneous fat. This tissue-selective lipid-modulating effect makes it a unique tool for investigating the metabolic differences between visceral and subcutaneous fat. Notably, in these studies, it is not employed as a conventional weight-loss drug; its primary target is visceral fat mass rather than total body weight.

Beyond the realm of lipid metabolism, the drug is widely used in research involving the growth hormone axis and endocrine regulation. Aging is accompanied by a gradual decline in the secretion of endogenous growth hormone-releasing hormone and a drop in growth hormone production—a state often referred to as "somatopause." In laboratory models, researchers use the drug to explore whether restoring this signaling pathway can reverse age-related changes in body composition. The drug-induced secretory activity helps promote nitrogen retention and protein anabolism while delaying the loss of lean tissue (lean body mass). Furthermore, researchers are investigating its effects on the extracellular matrix, collagen synthesis, and the remodeling of skin connective tissue.

Metabolism and inflammation research represents another key area of ​​application. Visceral fat functions as an active endocrine organ capable of secreting various pro-inflammatory cytokines; consequently, reducing visceral fat may help lower levels of chronic low-grade inflammation. Relevant studies focus primarily on changes in inflammatory markers and fasting lipid profiles. However, experimental results vary depending on individual differences and the models employed: some studies show improved insulin sensitivity, while others observe no significant changes. When designing experiments, researchers must account for confounding factors such as baseline body composition, nutritional status, and the duration of administration.

It also serves as a tool compound in endocrine pharmacology research. Scientists use it to study growth hormone-releasing hormone receptor expression, receptor desensitization, and downstream signal transduction cascades. Thanks to chemical modifications designed to enhance its stability, it is particularly well-suited for investigating the effects of sustained pathway activation. In comparative pharmacological studies, it is frequently compared with endogenous analogues and other secretagogues. The research team has also evaluated the bioavailability of this peptide.